UPDATE : Saturday, February 22, 2020
Samsung BioLogics files administrative suit to refute accounting fraud ruling by Nam Doo-hyun 2018-11-28 15:30
Bayer’s liver cancer drug proves efficacy with real-world data by Nam Doo-hyun 2018-11-27 14:27
Pharmaceuticals, biotechs rise with KOSPI rebound by Nam Doo-hyun 2018-11-27 11:53
Pharmaceuticals still use credit card kiting for illegal cash rebates by Nam Doo-hyun 2018-11-26 15:01
Operating income declines at top 10 biotechs on KOSDAQ by Nam Doo-hyun 2018-11-22 11:15
US data crucial for Korean biosimilars after success in Europe by Nam Doo-hyun 2018-11-21 15:29
MSD Korea improves employee welfare upon birth of union by Nam Doo-hyun 2018-11-21 12:56
‘Pay attention to expansion of US online pharmacy market’ by Nam Doo-hyun 2018-11-20 16:05
Samsung BioLogics fiasco hardly affects biotech stocks by Nam Doo-hyun 2018-11-16 11:30
‘Team up with multinationals to become multinational’ by Nam Doo-hyun 2018-11-15 11:20
Seoul mayor vows to support biomedical industry by Nam Doo-hyun 2018-11-14 15:34
Orders for ingredients of antitussives, expectorants surge amid fine dust by Nam Doo-hyun 2018-11-14 11:48
Pharmaceuticals oppose Korea-US FTA’s follow-up steps by Nam Doo-hyun/So Jae-hyeon 2018-11-12 15:53
'Biosimilar makers to benefit from new research accounting guideline' by Nam Doo-hyun 2018-11-07 11:23
Market caps of top 20 drugmakers on KOSPI surged this year by Nam Doo-hyun 2018-11-06 15:41
Will PharmAbcine be new force on KOSDAQ? by Nam Doo-hyun 2018-11-05 16:32
‘Physicians’ ability to analyze big data, use AI getting crucial’ by Nam Doo-hyun 2018-11-01 16:22
Oriental medical schools fail to get listed on world directory of medical schools by Nam Doo-hyun 2018-11-01 15:52
'More N. Korean statistics needed for inter-Korean healthcare cooperation’ by Nam Doo-hyun 2018-10-31 15:10
Korea’s drug exports to US inch down this year by Nam Doo-hyun 2018-10-31 12:22
Back to Top